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Abstract: 4-Bromoacetophenone is an acetophenone derivative known for its usefulness in organic coupling reactions and 
various biological applications. The aim of the study was to evaluate the impact of biofield energy treatment on 4-
bromoacetophenone using various analytical methods. The material is divided into two groups for this study i.e. control and 
treated. The control group remained as untreated and the treated group was subjected to Mr. Trivedi’s biofield energy 
treatment. Then, both the samples were characterized using X-ray diffraction (XRD), differential scanning calorimetry (DSC), 
thermogravimetric analysis (TGA), Fourier transform infrared (FT-IR), gas chromatography-mass spectrometry (GC-MS), and 
UV-visible spectrometry (UV-vis). The XRD study revealed that the crystallite size of treated 4-bromoacetophenone was 
decreased significantly to 16.69% with decreased intensity as compared to the control. The thermal studies revealed that the 
slight change was observed in the melting point and latent heat of fusion (∆H) of biofield energy treated sample as compared 
to the control. Maximum degradation temperature (Tmax) of treated 4-bromoacetophenone was decreased by 7.26% as 
compared to the control (169.89°C→157.54°C). The FT-IR spectra showed that the C=O stretching frequency at 1670 cm-1 
was shifted to higher frequency region (1672 in T1 and 1685 cm-1 in T2, in two treated samples for FT-IR) after biofield 
energy treatment. Moreover, the GC-MS data revealed that the isotopic abundance ratio of either 13C/12C or 2H/1H (PM+1)/PM 
was decreased up to 9.12% in T2 sample whereas increased slightly up to 3.83% in T3 sample. However, the isotopic 
abundance ratio of either 81Br/79Br or 18O/16O (PM+2)/PM of treated 4-bromoacetophenone was decreased from 0.10% to 
1.62% (where PM-primary mass of the molecule, (PM+1) and (PM+2) are isotopic mass of the molecule). The UV spectra 
showed the similar electronic behavior like absorption maximum in control and treated samples. Overall, the experimental 
results suggest that Mr. Trivedi’s biofield energy treatment has significant effect on the physical, thermal, and spectral 
properties of 4-bromoacetophenone.  
Keywords: 4-Bromoacetophenone, Biofield Energy Treatment, Fourier Transform Infrared,  
Differential Scanning Calorimetry, Thermogravimetric Analysis, X-ray Diffraction,  
Gas Chromatography-Mass Spectrometry 
 
1. Introduction 
4-Bromoacetophenone is basically a natural product and 
found in the environment as degradation products of 
industrial chemicals. It is used as a basic starting material in 
most of the metal catalyzed coupling reactions due to the 
presence of both electron-rich and electron-withdrawing 
functionalities within the same molecule [1]. In biological 
systems, halogen bonding has its importance due to their high 
directionality and specificity. Therefore, they can be used 
effectively in drug design to direct the binding of ligands to 
the target sites [2]. The bromoacetophenone derivatives upon 
excitation with ultraviolet radiation can generate phenyl 
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radicals. The utility of haloarenes were studied by Paul et al., 
as radical progenitors for DNA cleavage. It is reported that 
haloarenes are readily available compounds upon UV 
excitation and halo acetophenones are effective DNA 
cleaving agents [3, 4]. 4-Bromoacetophenone has been used 
as basic starting material in coupling reactions such as Heck 
coupling, Suzuki coupling, and Stille reactions [5]. 
Furthermore, guaiacyl, syringyl, and p-hydroxyphenyl-type 
bromoacetophenone derivatives were synthesized as the 
starting materials for β-O-4 type artificial lignin polymers 
[6]. Apart from that, the acetophenones were screened for 
activity against positive phototaxis of Chlamydomonas cells, 
a process that requires coordinated flagellar motility. Several 
acetophenones including 3, 4-dimethylacetophenone, and 4-
ethylacetophenone showed inhibitory effects on phototaxis in 
Chlamydomonas, in a concentration-dependent manner, 
indicating that these compounds nonspecifically interfere 
with phototaxis by disrupting overall cell viability [7]. 
Due to their wide range of applications in biology and 
synthetic organic chemistry, the objective of the current study 
was to evaluate the impact of biofield energy treatment on 
the physical and chemical properties of 4-
bromoacetophenone. The biofield is defined as the complex 
dynamic electromagnetic (EM) field. The field resulting from 
the EM fields contributed by each individual oscillator or 
electrically charged ensemble of particles of the body (ion, 
molecule, cell, tissue, etc.) [8, 9]. The term “biofield” has 
been accepted by the U.S. National Library of Medicine as a 
medical subject heading [10]. The biofield, which surrounds 
the human body, can be harnessed from the Universe. It has 
been applied on materials or living things by experts in a 
controlled way to make the changes [11]. Mr. Trivedi’s 
unique biofield energy treatment is known as The Trivedi 
Effect® [12]. The Trivedi Effect has been applied in various 
research fields including microbiology research [13], 
agriculture research [14, 15], and biotechnology research 
[16]. Thus, by observing the various transformations 
happened due to the unique biofield treatment of Mr. Trivedi,  
this study aimed to evaluate the impact of biofield energy 
treatment on 4-bromoacetophenone with respect to their 
physical, thermal and spectral properties. 
2. Materials and Methods 
2.1. Study Design 
4-Bromoacetophenone was procured from Loba Chemie 
Pvt. Ltd., India. The compound was divided into two parts 
i.e. control and treated. The control sample was remained as 
untreated and the treated sample in sealed pack was given to 
Mr. Trivedi for biofield energy treatment. Mr. Trivedi 
provided the treatment through his energy transmission 
process to the treated group. The control and treated samples 
were evaluated using various physical, thermal and 
spectroscopic techniques. 
Percent change in various parameters in treated sample 
with respect to control was calculated using the following 
equation: 
% change =

Treated − Control
Control
× 100 
2.2. X-ray Diffraction (XRD) Study 
The X-ray powder diffraction studies were carried out to 
characterize the crystallinity of 4-bromoacetophenone using 
Phillips, Holland PW 1710 X-ray diffractometer system, with 
radiation of wavelength 1.54056 Å in the 2θ range 10°-
99.99°. The crystallite size (G) was calculated by using the 
formula: G = kλ/(bCosθ). Here, λ is the wavelength of 
radiation, θ is the corresponding Bragg angle, b is full-width 
half maximum (FWHM) of the peaks and k is the equipment 
constant (=0.94). 
2.3. Differential Scanning Calorimetry (DSC) Study 
The DSC thermogram of 4-bromoacetophenone was 
acquired using Perkin Elmer/Pyris-1, USA at the flow rate of 
5 mL/min using closed aluminum pan to determine the 
melting temperature and latent heat of fusion. 
2.4. Thermogravimetric Analysis (TGA)/ Derivative 
Thermogravimetry (DTG) 
TGA/DTG results were obtained using Mettler Toledo 
simultaneous thermogravimetric analyzer at a heating rate of 
5ºC/min from room temperature to 400ºC under air 
atmosphere. 
2.5. FT-IR Spectroscopic Analysis (FT-IR) 
FT-IR characterization was done with Shimadzu Fourier 
transform infrared spectrometer (Japan) with the frequency 
range of 500-4000 cm-1. 4-bromoacetophenone was run as 
pressed disks using KBr as the diluent. 
2.6. GC-MS Spectrometry Analysis 
The gas chromatography-mass spectrometry (GC-MS) 
analysis was performed on Perkin Elmer/auto system XL 
with Turbo Mass, USA, having detection limit up to 1 
picogram. The GC-MS spectrum was obtained as % 
abundance vs. mass to charge ratio (m/z). The isotopic ratio 
of (PM+1)/PM and (PM+2)/PM was expressed by its 
deviation in treated samples as compared to the control. 
2.7. UV-Vis Spectroscopic Analysis 
UV-Vis spectra of control and treated samples were 
obtained from Shimadzu UV spectrophotometer (2400 PC) 
with quartz cell of 1 cm and a slit width of 2.0 nm. The 
analysis was done at the wavelength range of 200-400 nm. 
3. Results and Discussion 
3.1. XRD Studies 
The XRD study was conducted on both control and treated 
samples of 4-bromoacetophenone and diffractograms are 
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shown in Figure 1. Both control and treated 4-
bromoacetophenone samples exhibited very sharp and 
intense peaks of intensity 1350 a.u. and 630 a.u., respectively 
in their X-ray diffractogram. The control 4-
bromoacetophenone exhibited the XRD peaks at 2θ equal to 
19.05°, 28.71°, 38.57°, and 49.04° (Table 1). However, the 
XRD diffractogram of treated 4-bromoacetophenone showed 
the XRD peaks at 2θ equal to 18.91°, 20.45°, 23.28°, 28.57°, 
38.46°, and 48.62 °, with decreased intensity as compared to 
the control. The crystallite size was calculated using Scherrer 
formula and found decreased after biofield treatment by 
16.69% in the treated 4-bromoacetophenone. It was reported 
that the strain produced by energy milling had reduced the 
crystallite size in the crystal [17]. Thus, it is assumed that 
biofield energy treatment might induce the energy that causes 
milling in the treated 4-bromoacetophenone which is 
responsible for a decrease in crystallite size. 
Table 1. XRD analysis of control and treated 4-bromoacetophenone. 
 2θ FWHM of peak intensity 100% 
Crystallite size 
‘G’ x 10-9 m 
Percent change in 
‘G’ wrt control 
Control 19.05, 28.71, 38.57, 49.04 0.12 85.43  
Treated 18.91, 20.45, 23.28, 28.57, 38.46, 48.62 0.14 71.17 -16.69 
FWHM: full width half maximum, wrt: with respect to. 
 
Fig. 1. X-ray diffractograms of control and treated samples of 4-bromoacetophenone. 
3.2. DSC Analysis 
Measurement of melting point and latent heat of fusion 
(∆H) was done using DSC analysis. The melting point and 
∆H of control and treated samples of 4-bromoacetophenone 
are presented in Table 2. The latent heat of fusion (∆H) was 
decreased in the treated 4-bromoacetophenone from 230.55 
J/g to 228.38 J/g. A lower melting point was observed in the 
treated 4-bromoacetophenone (54.44°C) as compared to the 
control sample (55.22°C), (Table 2). This result showed that 
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treated 4-bromoacetophenone sample needed less energy in 
the form of ∆H to undergo the process of melting at a lower 
temperature after biofield energy treatment. It is 
hypothesized that the biofield energy might reduce the 
intermolecular force in the treated 4-bromoacetophenone 
molecules, which possibly decrease the melting point and 
latent heat of fusion. 
Table 2. DSC analysis of control and treated 4-bromoacetophenone. 
Parameter Control Treated 
Percent 
change 
Latent heat of fusion ∆H (J/G) 230.35 228.38 -0.85 
Melting point (°C) 55.22 54.44 -1.41 
3.3. TGA/DTG Analysis 
The TGA/DTG thermograms of both control and treated 
samples of 4-bromoacetophenone are shown in Figure 2. 
TGA curve showed that the control and treated samples were 
degraded in one step. In control 4-bromoacetophenone, the 
onset temperature was at 128.69°C and endset at 199.86°C. 
However, in treated sample, onset temperature was observed 
at 124.95°C and endset at 186.66°C. In this process, the 
control sample lost 59.24% of its initial weight, whereas 
treated sample lost 57.44% of its initial weight. The DTG 
thermogram showed the Tmax at 169.89°C and 157.54°C, 
respectively in the control and treated sample. Thus, the 
decrease in maximum degradation temperature of treated 4-
bromoacetophenone can be related to decreasing in thermal 
stability. The overall decreases in thermal stability of treated 
sample might be advantageous to be used as a reaction 
intermediate in coupling and photo excitation reactions. 
 
Fig. 2. TGA-DTG thermogram of control and treated samples of 4-bromoacetophenone. 
3.4. FT-IR Analysis 
The treated sample of 4-bromoacetophenone was divided 
into two parts as T1, and T2. The FT-IR spectra of control 
and treated samples of 4-bromoacetophenone are presented 
in Figure 3. The FT-IR spectra showed the aromatic C-H 
stretching frequency at 3010 cm-1 for control and treated 
samples of 4-bromoacetophenone. The IR spectra of control 
4-bromoacetophenone sample showed C=O stretching at 
1670 cm-1, however in treated samples the C=O stretching 
frequency shifted to higher energy region (T1=1672 cm-1, 
T2=1685 cm-1). The carbon-halogen bond is stronger 
covalent bond and it can be easily identifiable and appeared 
at 609 cm-1, for the C−Br bending vibration in both control 
and treated samples. The absorption at 1587 cm-1 and 1359 
cm-1 in control sample are due to the C=C stretching in 
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aromatic ring (1359 cm-1) was first reduced to 1354 cm-1 and 
then increased to 1361 cm-1 in the treated T1 and T2 samples 
respectively. Furthermore, the C-H deformation bends were 
assigned to the peaks at 1269 cm-1 in both control and treated 
samples of 4-bromoacetophenone. The FT-IR spectra 
indicated that there was a slight alteration in the C=O and 
C=C stretching frequencies in the treated 4-
bromoacetophenone, which increased after biofield energy 
treatment. The FT-IR results did not show any major changes 
in vibrational frequencies for the aromatic C-H stretching 
frequencies. The FT-IR spectral data is well matched with the 
literature data [18]. 
 
Fig. 3. FT-IR spectra of control and treated samples of 4-bromoacetophenone. 
3.5. GC-MS Analysis  
The treated sample of 4-bromoacetophenone was divided 
into four parts as T1, T2, T3, and T4. The mass spectra of 
control and treated samples of 4-bromoacetophenone are 
shown in Figure 4(a) and 4(b), respectively. The mass spectra 
showed the PM (primary molecule) peak at m/z = 198 in the 
control and treated samples of 4-bromoacetophenone. The 
m/z peak intensity, intensity ratio and isotopic abundance 
ratio of (PM+1)/PM and (PM+2)/PM peaks are presented in 
Table 3. There were six major peaks observed in both control 
and treated samples of 4-bromoacetophenone. The peaks are 
at m/z = 198, 183, 155, 76, 50 and 43 due to 4-
bromoacetophenone and its degraded products. The 
degradation of 4-bromoacetophenone, corresponded to the 
following ions: C8H9Br
+ (p-bromoehtylbenzene), C6H5Br
+ 
(bromobenzene), C6H5
+ (benzene), C4H2
+ (1, 3-butadyine) 
and C2H4O
+ (acetaldehyde), respectively were well matched 
with the reported GC-MS data [19]. The treated 4-
bromoacetophenone samples (T1-T4) were fragmented in a 
similar way with varied intensities as the control sample. 
Isotopic abundance ratio of (PM+1)/PM and (PM+2)/PM in 
4-bromoacetophenone was calculated and presented in Figure 
5. It is seen from the Figure 5 that the isotopic abundance 
ratio of (PM+1)/PM in 4-bromoacetophenone was increased 
by 3.83% in T3 sample, while it was decreased by 9.12% in 
treated, T2 sample as compared to the control. However, the 
isotopic abundance ratio of (PM+2)/PM in 4-
bromoacetophenone was decreased from 0.1 to 1.62% in T1 
to T4 samples, as compared to the control. The biofield 
treatment may have altered the isotopic abundance ratio of 
(PM+1)/PM and (PM+2)/PM of treated 4-
bromoacetophenone from the control sample. Furthermore, it 
is assumed that the lower isotopic ratio of (PM+1)/PM and 
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(PM+2)/PM, might have decreased the stability of the 
compound due to the decreased µ (reduced mass) and 
binding energy in molecules with lighter isotopic bonds. This 
lower binding energy may lead to decrease the bond strength 
for treated 4-bromoacetophenone, however, the reverse might 
happen in treated T3 sample [20]. It is reported that the 
isotope fractionation for bromine and oxygen is slower than 
chlorine, carbon, hydrogen, and nitrogen, which is much 
dependent on the reaction path (kinetic) of organohalogen 
compounds [21], and we have observed a slow depletion of 
(PM+2)/PM ratio (1.62%). Thus, GC-MS data suggested that 
biofield treatment has significantly altered the isotopic ratio 
of in treated 4-bromoacetophenone molecule. 
 
Fig. 4(a). GC-Mass spectra of control sample of 4-bromoacetophenone. 
 
Fig. 4(b). GC-MS spectra of treated (T1, T2, T3 and T4) samples of 4-bromoacetophenone. 
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Fig. 5. Percent change in isotopic abundance ratio of (PM+1)/PM and 
(PM+2)/PM in treated samples of 4-bromoacetophenone. 
Table 3. GC-MS isotopic abundance analysis result of 4-
bromoacetophenone. 
Parameter Control Treated 
  
T1 T2 T3 T4 
Peak intensity at m/z= (PM) 21.93 20.47 66.46 23.00 22.74 
Peak intensity at m/z= (PM+1) 1.91 1.72 5.26 2.08 1.96 
Peak intensity at m/z= (PM+2) 21.38 19.77 64.04 22.04 21.82 
Percent change of isotopic 
abundance in (PM+1)/PM 
 -3.52 -9.12 3.83 -4.06 
Percent change of isotopic 
abundance in (PM+2)/PM 
 -0.93 -1.16 -0.1 -1.62 
 
Fig. 6. UV-Vis spectra of control and treated 4-bromoacetophenone sample. 
3.6. UV-Vis Analysis 
The UV spectra of control and treated 4-
bromoacetophenone are shown in Figure 6. The UV 
spectrum of control sample showed the absorbance maxima 
(λmax) at 205 and 254 nm. Similarly, the spectra of treated 
sample showed the λmax at 203 and 254 nm. The peak at 254 
nm absorption maximum in control sample did not show any 
shift of wavelength after biofield energy treatment. However, 
the peak at higher energy region showed a minor blueshift 
from 205 nm (control) to 203 nm (treated). The result 
showed that similar pattern but a minor shift of absorbance 
maxima was exibited by the treated sample as compared to 
the control. Therefore, it is suggested that the biofield 
treatment did not disturb the HOMO-LUMO energy gap in 
the treated sample as compared to the control. 
4. Conclusion 
In summary, the crystallite size was significantly decreased 
by 16.69% with decreased intensity of the diffractogram in 
treated 4-bromoacetophenone as compared to the control. 
The melting point, latent heat of fusion, and Tmax were 
decreased slightly by 1.42 %, 0.85 %, and 7.26%, 
respectively in the treated sample as compared to the control,  
indicated the reduced thermal stability of the biofield treated 
4-bromoacetophenone. The isotopic abundance ratio of 
(PM+1)/PM of treated 4-bromoacetophenone was 
significantly decreased to 9.12% in T2 and slight increased 
up to 3.83 % in T3 sample as compared to the control. 
However, the isotopic abundance ratio of (PM+2)/PM in 
treated 4-bromoacetophenone was decreased by 1.62%. It is 
assumed that due to the lowering of isotopic abundance ratio 
of (PM+1)/PM and (PM+2)/PM of treated 4-
bromoacetophenone, with lower binding energy may lead to 
lowering of chemical stability than the control sample. The 
lowering of isotopic abundance is well corroborated with the 
shifting of C=O and C=C peak to higher wavenumber region 
in FT-IR spectra. It is assumed that the lowering of thermal 
stability in treated 4-bromoacetophenone could make it 
useful as a reaction intermediate in various coupling 
reactions and in the synthesis of polymers. 
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